Suchergebnisse
AbbVie Inc.
WKN: A1J84E / Symbol: ABBV / Name: AbbVie / Aktie / Pharmazeutika / Large Cap /
ABB Ltd. ADR
WKN: 675089 / Symbol: ABB / Name: ABB / Aktie / Maschinen, Ausrüstung & Teile / Large Cap /
Abbott Laboratories
WKN: 850103 / Symbol: ABT / Name: Abbott / Aktie / Pharmazeutika / Large Cap /
Abbott Ireland Financing Dac
WKN: A2SAR0 / Name: Abbott Ireland Financing Dac / Aktie / ? /
Abbott Ireland Financing Dac
WKN: A2RSC7 / Name: Abbott Ireland Financing Dac / Aktie / ? /
AbbVie (ABBV) Stock Drops Despite Market Gains: Important Facts to Note
AbbVie (ABBV) closed at $249.91 in the latest trading session, marking a -1.12% move from the prior day. The stock fell short of the S&P 500, which registered a gain of 0.81% for the day. At the
AbbVie Inc. (ABBV) Is a Trending Stock: Facts to Know Before Betting on It
AbbVie (ABBV) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at some of the facts that could shape the stock's performance in the near term.
Over the
Should You Buy, Sell or Hold ABBV Stock After Its 9% YTD Rise?
AbbVie ABBV stock has risen 8.9% so far this year as investor confidence strengthened in the company's post-Humira growth strategy. Despite Humira's U.S. patent expiry in 2023, AbbVie has
ABB (ABBNY) Reports Q2 Earnings: What Key Metrics Have to Say
For the quarter ended June 2026, ABB (ABBNY) reported revenue of $9.48 billion, up 6.5% over the same period last year. EPS came in at $0.66, compared to $0.63 in the year-ago quarter.
The reported